184 related articles for article (PubMed ID: 17550963)
1. The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion.
Joseph F; Chan BY; Durham BH; Ahmad AM; Vinjamuri S; Gallagher JA; Vora JP; Fraser WD
J Clin Endocrinol Metab; 2007 Aug; 92(8):3230-8. PubMed ID: 17550963
[TBL] [Abstract][Full Text] [Related]
2. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency.
Ahmad AM; Hopkins MT; Fraser WD; Ooi CG; Durham BH; Vora JP
Bone; 2003 Feb; 32(2):170-9. PubMed ID: 12633789
[TBL] [Abstract][Full Text] [Related]
4. PTH circadian rhythm and PTH target-organ sensitivity is altered in patients with adult growth hormone deficiency with low BMD.
White HD; Ahmad AM; Durham BH; Peter R; Prabhakar VK; Corlett P; Vora JP; Fraser WD
J Bone Miner Res; 2007 Nov; 22(11):1798-807. PubMed ID: 17645402
[TBL] [Abstract][Full Text] [Related]
5. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption.
Ledger GA; Burritt MF; Kao PC; O'Fallon WM; Riggs BL; Khosla S
J Clin Endocrinol Metab; 1995 Nov; 80(11):3304-10. PubMed ID: 7593443
[TBL] [Abstract][Full Text] [Related]
6. Circasemidian rather than circadian variation of circulating osteoprotegerin in clinical health.
Tarquini R; Mazzoccoli G; Dolenti S; Gaudiano P; Comuni C; Laffi G; Perfetto F; Otsuka K; Cornélissen G; Halberg F
Biomed Pharmacother; 2005 Oct; 59 Suppl 1(Suppl 1):S225-8. PubMed ID: 16275499
[TBL] [Abstract][Full Text] [Related]
7. The effect of timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal osteoporosis.
Luchavova M; Zikan V; Michalska D; Raska I; Kubena AA; Stepan JJ
Eur J Endocrinol; 2011 Apr; 164(4):643-8. PubMed ID: 21289031
[TBL] [Abstract][Full Text] [Related]
8. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
9. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
Ahmad AM; Thomas J; Clewes A; Hopkins MT; Guzder R; Ibrahim H; Durham BH; Vora JP; Fraser WD
J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
[TBL] [Abstract][Full Text] [Related]
10. Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis.
Fraser WD; Logue FC; Christie JP; Gallacher SJ; Cameron D; O'Reilly DS; Beastall GH; Boyle IT
Osteoporos Int; 1998; 8(2):121-6. PubMed ID: 9666934
[TBL] [Abstract][Full Text] [Related]
11. Circadian variation in ionized calcium and intact parathyroid hormone: evidence for sex differences in calcium homeostasis.
Calvo MS; Eastell R; Offord KP; Bergstralh EJ; Burritt MF
J Clin Endocrinol Metab; 1991 Jan; 72(1):69-76. PubMed ID: 1986029
[TBL] [Abstract][Full Text] [Related]
12. Circadian rhythm and pulsatility of parathyroid hormone secretion in man.
Herfarth K; Schmidt-Gayk H; Graf S; Maier A
Clin Endocrinol (Oxf); 1992 Dec; 37(6):511-9. PubMed ID: 1286521
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
[TBL] [Abstract][Full Text] [Related]
14. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis.
Piatek S; Adolf D; Wex T; Halangk W; Klose S; Westphal S; Amthauer H; Winckler S
Maturitas; 2013 Apr; 74(4):363-8. PubMed ID: 23391500
[TBL] [Abstract][Full Text] [Related]
15. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.
Giusti M; Cecoli F; Fazzuoli L; De Franchis V; Ceresola E; Ferone D; Mussap M; Minuto F
Metabolism; 2007 May; 56(5):699-707. PubMed ID: 17445547
[TBL] [Abstract][Full Text] [Related]
16. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
17. Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women.
Rejnmark L; Vestergaard P; Heickendorff L; Andreasen F; Mosekilde L
Eur J Clin Invest; 2001 Sep; 31(9):764-72. PubMed ID: 11589718
[TBL] [Abstract][Full Text] [Related]
18. Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis.
Dovio A; Generali D; Tampellini M; Berruti A; Tedoldi S; Torta M; Bonardi S; Tucci M; Allevi G; Aguggini S; Bottini A; Dogliotti L; Angeli A
Osteoporos Int; 2008 Jan; 19(1):113-7. PubMed ID: 17703272
[TBL] [Abstract][Full Text] [Related]
19. Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study.
Szulc P; Hawa G; Boutroy S; Vilayphiou N; Schoppet M; Chapurlat R; Hofbauer LC
J Clin Endocrinol Metab; 2011 Jul; 96(7):2216-26. PubMed ID: 21565793
[TBL] [Abstract][Full Text] [Related]
20. Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women.
Ostrowska Z; Kos-Kudła B; Marek B; Kajdaniuk D; Wołkowska-Pokrywa K
Postepy Hig Med Dosw (Online); 2011 Oct; 65():658-67. PubMed ID: 22100799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
